此服務在您所在的地區不可用。

Alpha Management Limited

阿拉伯聯合酋長國

成立於

2007 (19 年)

成立

最後上線: 最近無活動

訪問網站

暫無 TrustScore分數不足，無法顯示趨勢。

成為首個為該公司評分與評論的使用者。

綜合得分

其他

--/10

評論

--/90

0 則評價

由 TrustFinance 提供

暫無 TrustScore分數不足，無法顯示趨勢。

成為首個為該公司評分與評論的使用者。

Markets.com

(326 評論)

United States

2008

(18 年)

安全資訊 :

FSCA

安全資訊

警告

該公司目前未經證實.

請注意潛在風險！

牌照

甲級牌照

由全球知名監管機構頒發，這些許可證透過嚴格的合規性、資金隔離、保險和定期審計，確保最高程度的交易者保護。爭議解決和遵守 AML/CTF 標準進一步提高了安全性。

B 級牌照

由受尊敬的區域監管機構授予，這些許可證提供強大的安全措施，例如資金隔離、財務報告和補償計劃。雖然沒有等級 1 那麼嚴格，但它們提供可靠的區域保護。

C 級牌照

由新興市場的監管機構頒發，這些許可證提供基本保護，例如最低資本要求和 AML 政策。監管較不嚴格，因此交易者應謹慎行事並驗證安全措施。

D 級牌照

來自監管最少的司法管轄區，這些許可證通常缺乏關鍵保護，例如資金隔離和保險。雖然它們對營運彈性很有吸引力，但它們對交易者構成較高的風險。

公司資料

了解 Alpha Management Limited

公司資料

了解 Alpha Management Limited

Founded in 2009, Alpha Management Limited is a management company licensed and regulated by the Financial Services Commission (FSC) of Mauritius. The company specializes in creating, managing, and administering cross-border investment structures for a diverse clientele, including institutional investors, fund managers, and high-net-worth individuals. Its core mission is to provide bespoke, flexible, and efficient solutions in corporate structuring, fund administration, and private wealth management, leveraging Mauritius's position as an international financial center.

行業

財務法律服務主要
財務投資
財務其他服務

軟件

無可用數據

呢個部分好似係空嘅。快啲返嚟睇更新！

聯絡

社交

公司尚未更新其資訊。

公司資料

了解 Alpha Management Limited

Founded in 2009, Alpha Management Limited is a management company licensed and regulated by the Financial Services Commission (FSC) of Mauritius. The company specializes in creating, managing, and administering cross-border investment structures for a diverse clientele, including institutional investors, fund managers, and high-net-worth individuals. Its core mission is to provide bespoke, flexible, and efficient solutions in corporate structuring, fund administration, and private wealth management, leveraging Mauritius's position as an international financial center.

行業

財務法律服務主要
財務投資
財務其他服務

軟件

無可用數據

呢個部分好似係空嘅。快啲返嚟睇更新！

聯絡

社交

公司尚未更新其資訊。

新聞

TrustFinance 情報機構

研究日期: 4月 28, 2026

AlphaSense is an AI-driven intelligence platform designed for comprehensive financial research, combining internal and external data sources. It features advanced tools for search, summarization, and monitoring, enabling users to extract insights efficiently. The platform offers a wide range of content, including equity research, expert interviews, and company documents, while integrating generative AI capabilities for enhanced analysis. Despite its strengths, it lacks some visualization and collaboration tools, and pricing varies based on user needs.

AlphaSense is an AI-driven intelligence platform designed for comprehensive financial research, combining internal and external data sources. It features advanced tools for search, summarization, and monitoring, enabling users to extract insights efficiently. The platform offers a wide range of content, including equity research, expert interviews, and company documents, while integrating generative AI capabilities for enhanced analysis. Despite its strengths, it lacks some visualization and collaboration tools, and pricing varies based on user needs.

Hub International Ltd. has been valued at $29 billion following a $1.6 billion equity investment led by T. Rowe Price, Alpha Wave Global, and Temasek. This marks a significant increase from its valuation of $4.4 billion in 2013. The firm provides employee and retirement benefits and has seen substantial revenue growth, with annual revenue rising to $4.9 billion in 2024. The investment is set to close in May, with expectations of increased price competition and consolidations in the insurance brokerage industry.

Hub International Ltd. has been valued at $29 billion following a $1.6 billion equity investment led by T. Rowe Price, Alpha Wave Global, and Temasek. This marks a significant increase from its valuation of $4.4 billion in 2013. The firm provides employee and retirement benefits and has seen substantial revenue growth, with annual revenue rising to $4.9 billion in 2024. The investment is set to close in May, with expectations of increased price competition and consolidations in the insurance brokerage industry.

BlackRock has introduced the AlphaAgents framework, which utilizes multi-agent systems to enhance equity portfolio construction through advanced AI techniques. The framework incorporates three specialized agents: a Fundamental Agent for analyzing company fundamentals, a Sentiment Agent for assessing market sentiment, and a Valuation Agent for evaluating stock prices. Each agent operates within a defined role to minimize cognitive biases and improve decision-making. The AlphaAgents framework aims to provide more robust investment strategies by leveraging collaborative reasoning and backtesting against market benchmarks. This innovation is positioned to transform asset management practices by offering scalable and explainable AI-driven portfolio management solutions.

BlackRock has introduced the AlphaAgents framework, which utilizes multi-agent systems to enhance equity portfolio construction through advanced AI techniques. The framework incorporates three specialized agents: a Fundamental Agent for analyzing company fundamentals, a Sentiment Agent for assessing market sentiment, and a Valuation Agent for evaluating stock prices. Each agent operates within a defined role to minimize cognitive biases and improve decision-making. The AlphaAgents framework aims to provide more robust investment strategies by leveraging collaborative reasoning and backtesting against market benchmarks. This innovation is positioned to transform asset management practices by offering scalable and explainable AI-driven portfolio management solutions.

Liminal BioSciences Inc. has completed a statutory plan of arrangement with Structured Alpha LP, acquiring all outstanding common shares not owned by SALP at a price of US$8.50 per share. Following the arrangement, the shares will no longer be listed on the Nasdaq Capital Market, and the company will seek to cease being a reporting issuer in Canada and suspend its reporting obligations in the U.S. Liminal BioSciences focuses on developing small molecule therapeutics targeting various diseases, with its clinical candidate LMNL6511 expected to enter Phase 1 trials in late 2023.

Liminal BioSciences Inc. has completed a statutory plan of arrangement with Structured Alpha LP, acquiring all outstanding common shares not owned by SALP at a price of US$8.50 per share. Following the arrangement, the shares will no longer be listed on the Nasdaq Capital Market, and the company will seek to cease being a reporting issuer in Canada and suspend its reporting obligations in the U.S. Liminal BioSciences focuses on developing small molecule therapeutics targeting various diseases, with its clinical candidate LMNL6511 expected to enter Phase 1 trials in late 2023.

The Investment Management Update from Skadden provides an overview of recent regulatory developments affecting the investment management sector, including amendments to fund names and beneficial ownership reporting rules by the SEC, enforcement actions against investment advisers and fund administrators for various violations, and proposed regulations addressing conflicts of interest in the use of predictive data analytics. Key highlights include changes to the Fund Names Rule requiring funds to adopt an 80% investment policy, accelerated filing deadlines for beneficial ownership disclosures, and new compliance requirements for investment advisers operating online. The update also discusses the SEC's focus on compliance and recordkeeping among broker-dealers and investment advisers.

The Investment Management Update from Skadden provides an overview of recent regulatory developments affecting the investment management sector, including amendments to fund names and beneficial ownership reporting rules by the SEC, enforcement actions against investment advisers and fund administrators for various violations, and proposed regulations addressing conflicts of interest in the use of predictive data analytics. Key highlights include changes to the Fund Names Rule requiring funds to adopt an 80% investment policy, accelerated filing deadlines for beneficial ownership disclosures, and new compliance requirements for investment advisers operating online. The update also discusses the SEC's focus on compliance and recordkeeping among broker-dealers and investment advisers.

由TrustFinance AI分析提供

新聞

TrustFinance 情報機構

研究日期: 4月 28, 2026

AlphaSense is an AI-driven intelligence platform designed for comprehensive financial research, combining internal and external data sources. It features advanced tools for search, summarization, and monitoring, enabling users to extract insights efficiently. The platform offers a wide range of content, including equity research, expert interviews, and company documents, while integrating generative AI capabilities for enhanced analysis. Despite its strengths, it lacks some visualization and collaboration tools, and pricing varies based on user needs.

Hub International Ltd. has been valued at $29 billion following a $1.6 billion equity investment led by T. Rowe Price, Alpha Wave Global, and Temasek. This marks a significant increase from its valuation of $4.4 billion in 2013. The firm provides employee and retirement benefits and has seen substantial revenue growth, with annual revenue rising to $4.9 billion in 2024. The investment is set to close in May, with expectations of increased price competition and consolidations in the insurance brokerage industry.

BlackRock has introduced the AlphaAgents framework, which utilizes multi-agent systems to enhance equity portfolio construction through advanced AI techniques. The framework incorporates three specialized agents: a Fundamental Agent for analyzing company fundamentals, a Sentiment Agent for assessing market sentiment, and a Valuation Agent for evaluating stock prices. Each agent operates within a defined role to minimize cognitive biases and improve decision-making. The AlphaAgents framework aims to provide more robust investment strategies by leveraging collaborative reasoning and backtesting against market benchmarks. This innovation is positioned to transform asset management practices by offering scalable and explainable AI-driven portfolio management solutions.

Liminal BioSciences Inc. has completed a statutory plan of arrangement with Structured Alpha LP, acquiring all outstanding common shares not owned by SALP at a price of US$8.50 per share. Following the arrangement, the shares will no longer be listed on the Nasdaq Capital Market, and the company will seek to cease being a reporting issuer in Canada and suspend its reporting obligations in the U.S. Liminal BioSciences focuses on developing small molecule therapeutics targeting various diseases, with its clinical candidate LMNL6511 expected to enter Phase 1 trials in late 2023.

The Investment Management Update from Skadden provides an overview of recent regulatory developments affecting the investment management sector, including amendments to fund names and beneficial ownership reporting rules by the SEC, enforcement actions against investment advisers and fund administrators for various violations, and proposed regulations addressing conflicts of interest in the use of predictive data analytics. Key highlights include changes to the Fund Names Rule requiring funds to adopt an 80% investment policy, accelerated filing deadlines for beneficial ownership disclosures, and new compliance requirements for investment advisers operating online. The update also discusses the SEC's focus on compliance and recordkeeping among broker-dealers and investment advisers.

由TrustFinance AI分析提供

Alpha Management Limited

Markets.com

公司資料

公司資料

評論